August 15, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader, is proud to announce that it has entered into an agreement with David Hawk, fitness expert and a former IFBB professional bodybuilder, who ranked in the top 10 of the world’s best professional bodybuilders from 1985 to 1992. Hawk will focus on business development of the Company’s wholly owned subsidiary, ISO-Sport, and will be instrumental in raising further awareness of the Company’s health and wellness CBD products for athletes around the world.
David Hawk is considered one of the world’s best professional trainers and nutrition coaches, and has worked with athletes in the NFL, NHL, PKA, IFL, NASCAR, WWE, TNA and UFC. In addition, he served as a NASCAR Busch Series pit crew trainer for GNC’s and Stackers teams, and advisor for DuPont’s (Nutrition and Health) Sports Nutrition division with Hendricks Motor Sports racing.
Over the past 25 years Mr. Hawk has worked as a consultant marketing specialist and business development director and ingredient educator for some of the largest health and wellness nutrition retailers, manufacturers and publishers in the world, including DuPont Nutrition and Health, Interhealth-USA, Milk Specialties, IDF, GNC, Vitamin Shoppe, Basic Media Group, AFFES Military Exchange, 7-eleven, Giant Eagle, and CVS pharmacies.
“It is truly a privilege to have David Hawk join the Iso-Sport Team,” said CEO of Isodiol, Marcos Agramont. “This is another example of our dedication to bring Iso-Sport CBD Performance Products to athletes around the globe.”
Mr. Hawk has also been a featured guest on Fox Sports Net’s Totally NASCAR, Sally Jesse Raphael, Regis Philbin, PM Magazine, ESPN, ESPN2, ESPN’s American Muscle Magazine, Muscle Sport USA, Benny Hinn Ministries, and Pat Robertson’s CBN 700 Club.
As a celebrity athlete, Mr. Hawk has published fitness and nutrition articles in national and international magazines including Muscle & Fitness, Flex, Ironman, Men’s Health, Muscular Development, Muscle Mag International, Muscle Training Illustrated, Physical, Get Active, Let’s Live, Fitness RX, Black Belt, Physique 3D, Muscle and Body, Wellbella, Real Fighter, Giant Eagle’s Healthy Advantage magazine, and the Europa World Sports magazines.
With the addition of Mr. Hawk to the Iso-Sport Team, the Company is confident it has added another strong pillar to its already solid foundation of relationships, such as Olympic Athlete Ambassadors, Cage Warriors, and the Iso-Sport Living Lab for athletes and trainers with Altis, in its quest to be the global leader in CBD Performance Products to athletes around the world.
About Isodiol International Inc.
Isodiol International Inc. is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of consumer products.
Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products and most recently received approval as having the first CBD designated as an Active Pharmaceutical Ingredient as was announced April 26, 2018.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
“Marcos Agramont” CEO & Director
COMPANY MEDIA :
Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend, to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.